Dermatology Times 2024 in Review: Psoriasis
As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in psoriasis this year.
As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in psoriasis this year.
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in atopic dermatitis this year.
Catch up on coverage of FDA-approved drugs in the first half of 2024.
Panelists discuss how hidradenitis suppurativa poses significant diagnostic and treatment challenges, while exploring current management approaches, emerging therapies, dosing considerations, and the potential of AI…
The 3rd Annual Pigmentary Disorders Exchange Symposium will bring back together world-renowned dermatology experts who will spend two full days diving deep into pigmentary disorders…
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Alexa Hetzel, MS, PA-C; Andrew Mastro, MS, PA-C; TJ Chao, MPAS, PA-C, and Terry Faleye, MPAS, PA-C, explore plaque psoriasis through patient case analyses and…
E. James Song, MD, FAAD, presents patient cases, discusses clinical practices, and provides comprehensive insights on the treatment landscape for plaque psoriasis.
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in aesthetic/cosmetic dermatology this year.
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.